Mitchell de Long

Corporate Officer/Principal en AERIE PHARMACEUTICALS, INC. .

Consumer Services

Consumer Non-Durables

Health Technology

Perfil

Mitchell A.
de Long is currently working as the Vice President-Chemistry at Aerie Pharmaceuticals, Inc. He previously worked as a Research Scientist at Procter & Gamble Co. Dr. de Long holds a doctorate degree from Stanford University.

Cargos activos de Mitchell de Long

Empresas	Cargo	Inicio
AERIE PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2005

Todos los cargos activos de Mitchell de Long

Antiguos cargos conocidos de Mitchell de Long.

Empresas	Cargo	Fin
PROCTER & GAMBLE COMPANY	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Mitchell de Long.

Formación de Mitchell de Long.

Stanford University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mitchell de Long.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
PROCTER & GAMBLE COMPANY	Consumer Non-Durables

Empresas privadas	1
Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.	Health Technology